Rocky Hill-based Lumeda, a startup that is developing an optical device to target cancer-killing laser light during lung cancer surgery, has named its first CEO.
Alexander “Sandy” Zinke has worked in various marketing and business development executive positions for medical device companies in Massachusetts and New York — including Boston Scientific, Hologic and CDx Diagnostics — where he has been involved in developing and commercializing more than a dozen products and programs.
Lumeda was founded by Trevor MacDougall and Paul E. Sanders, whose prior photonics ventures found some success in the energy industry.
